Both in Pharmaceuticals
Apimeds Pharmaceuticals US vs Dermata Therapeutics
Over the past year APUS returned −88.0% and DRMA returned −75.2%; their daily moves had a correlation of 0.01.
APUS −88.0% DRMA −75.2%Growth of $1, one year, split-adjusted
| Metric | APUS | DRMA |
|---|---|---|
| Price | $2.97 | $0.8487 |
| Market cap | $4.5M | $4.2M |
| Today | +2.77% | +12.59% |
| 1 month | −35.3% | −23.5% |
| 6 months | −90.1% | −34.7% |
| Year to date | −81.9% | −63.4% |
| 1 year | — | −75.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$8.6M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 264.0% | 132.3% |
| Short % of float | 0.9% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).